The Final 10-Year Follow-Up Results From the BARI Randomized Trial

Investigators, Bari D

doi:10.1016/j.jacc.2006.11.048

Cited by 383 publications

(61 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…• In BARI 2D study [79,80] authors randomized 2,368 patients with type 2 diabetes and chronic coronary artery disease to initial strategy of optimal medical therapy or medical treatment with percutaneous or surgical revascularization. There was no difference between groups in relation to survival in a follow-up of 5 years (87.8% in the medical therapy group vs. 88.3% in the revascularized group, p = 0.97).…”

Section: Methodsmentioning

confidence: 99%

Diabetes and cardiovascular disease: from evidence to clinical practice – position statement 2014 of Brazilian Diabetes Society

Bertoluci

Pimazoni-Netto

Pires

et al. 2014

Diabetol Metab Syndr

View full text Add to dashboard Cite

There is a very well known correlation between diabetes and cardiovascular disease but many health care professionals are just concerned with glycemic control, ignoring the paramount importance of controlling other risk factors involved in the pathogenesis of serious cardiovascular diseases. This Position Statement from the Brazilian Diabetes Society was developed to promote increased awareness in relation to six crucial topics dealing with diabetes and cardiovascular disease: Glicemic Control, Cardiovascular Risk Stratification and Screening Coronary Artery Disease, Treatment of Dyslipidemia, Hypertension, Antiplatelet Therapy and Myocardial Revascularization. The issue of what would be the best algorithm for the use of statins in diabetic patients received a special attention and a new Brazilian algorithm was developed by our editorial committee. This document contains 38 recommendations which were classified by their levels of evidence (A, B, C and D). The Editorial Committee included 22 specialists with recognized expertise in diabetes and cardiology.

show abstract

Section: Methodsmentioning

confidence: 99%

Diabetes and cardiovascular disease: from evidence to clinical practice – position statement 2014 of Brazilian Diabetes Society

Bertoluci

Pimazoni-Netto

Pires

et al. 2014

Diabetol Metab Syndr

View full text Add to dashboard Cite

show abstract

“…The 10-year results of the BARI [9] showed that there was no significant long-term disadvantage regarding mortality or myocardial infarction associated with an initial strategy of PCI compared with CABG. Among patients with treated diabetes, CABG conferred long term survival benefit, whereas the 2 initial strategies were equivalent regarding survival for patients without diabetes.…”

Section: Bari (Bypass Angioplasty Revascularization Investigation)mentioning

confidence: 99%

Review: Outcomes of Revascularization Strategies for Coronary Artery Disease

Albacker¹,

Albackr²,

Shamiri³

et al. 2014

IJCM

View full text Add to dashboard Cite

The optimal revascularization strategy for patients with coronary artery disease is influenced by the continuous improvement in medical therapy and the improved designs of the new generation of coronary stents allowing them to be increasingly applied in patients with complex coronary anatomy, including those with left main stem disease. On the other hand, surgical results are also improved as a result of the increased experience over years and the improvement of myocardial protection techniques. This will make the comparison of percutaneous coronary interventions and coronary artery bypass surgery a moving target. In this paper, we reviewed the recent randomized controlled trials and important registries emphasizing the benefits and the results of each therapy in different patient subsets. A heart team of both cardiologists and cardiac surgeons is of paramount importance in choosing the optimal revascularization strategy.

show abstract

“…The survival benefit of CABG in patients with diabetes persisted at 10 years (PTCA 45.5% vs. CABG 57.8%, P =0.025) [17]. In an analysis based on pooled individual patient data from 10 randomized trials comparing CABG with PCI (median follow-up of 5.9 years), mortality among patients with DM was 30% lower in the CABG group than in the PCI group (hazard ratio [HR] 0.70; 95% CI 0.56–0.87; P =0.014 for the interaction between DM and type of revascularization) [18].…”

Section: Cabg Versus Pci In Multivessel Cadmentioning

confidence: 99%

“…Importantly, follow-up at 1-year may not yet reflect the true long-term differences between CABG and DES treatment of patients with DM because previous reports demonstrated reduced long-term mortality in CABG compared with PCI [17,18]. Finally, few data are available with regard to the long-term clinical implications and risks associated with of the ‘softer’ endpoint of repeat revascularization.…”

Section: Cabg Versus Pci In Multivessel Cadmentioning

confidence: 99%

Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus

Aronson

Edelman

2012

Current Opinion in Pharmacology

View full text Add to dashboard Cite

Multiple studies have shown that diabetes mellitus (DM) can affect the efficacy of revascularization therapies and subsequent clinical outcomes. Selection of the appropriate myocardial revascularization strategy is critically important in the setting of multivessel coronary disease. Optimal medical therapy is an appropriate first-line strategy in patients with DM and mild symptoms. When medical therapy does not adequately control symptoms, revascularization with either PCI or CABG may be used. In patients with treated DM, moderate to severe symptoms and complex multivessel coronary disease, coronary artery bypass graft surgery provides better survival, fewer recurrent infarctions and greater freedom from re-intervention. Decisions regarding revascularization in patients with DM must take into account multiple factors and as such require a multidisciplinary team approach (‘heart team’).

show abstract

The Final 10-Year Follow-Up Results From the BARI Randomized Trial

Cited by 383 publications

References 16 publications

Diabetes and cardiovascular disease: from evidence to clinical practice – position statement 2014 of Brazilian Diabetes Society

Diabetes and cardiovascular disease: from evidence to clinical practice – position statement 2014 of Brazilian Diabetes Society

Review: Outcomes of Revascularization Strategies for Coronary Artery Disease

Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus

Contact Info

Product

Resources

About